Champions Oncology (CSBR) Accumulated Expenses (2011 - 2026)

Champions Oncology (CSBR) has 16 years of Accumulated Expenses data on file, last reported at $2.7 million in Q3 2026.

• On a quarterly basis, Accumulated Expenses rose 48.58% year-over-year to $2.7 million in Q3 2026; TTM through Jul 2026 was $2.7 million, a 48.58% increase from a year earlier, with the FY2026 full-year figure at $2.6 million, up 1.41% from the prior year.
• Accumulated Expenses for Q3 2026 stood at $2.7 million, up from $2.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.3 million in Q1 2026 and bottomed at $1.7 million in Q4 2022.
• Historically, Accumulated Expenses has averaged $2.3 million across 5 years, with a median of $2.2 million in 2025.
• The widest annual swing landed in 2025, when Accumulated Expenses dropped 14.12%; it then soared 48.58% in 2026.
• Year by year, Accumulated Expenses stood at $1.7 million in 2022, then grew by 21.14% to $2.0 million in 2023, then increased by 10.48% to $2.2 million in 2024, then fell by 2.1% to $2.2 million in 2025, then rose by 22.3% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $2.7 million in Q3 2026, $2.6 million in Q2 2026, and $3.3 million in Q1 2026.